| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.69 MB | Adobe PDF |
Abstract(s)
Introdução: A dor é um sintoma preponderante na clínica reumatológica, chegando a ser a
razão principal de o doente procurar um médico. Ela tem um impacto significativo na vida das
pessoas afetadas com repercussões a nível físico, psicológico, social e económico. Deste modo,
o tratamento e controlo adequado da dor é um dever dos médicos e dos profissionais de saúde
e um direito dos doentes que dela sofrem. No entanto, o tratamento por vezes é difícil,
especialmente quando se trata de dor crónica. Assim, é importante fazer o estudo da
medicação usada na dor, não só pelo seu valor epidemiológico e evolutivo, mas também para
conhecer alternativas à medicação antiálgica convencional.
Objetivos: Este estudo foi desenvolvido com o propósito de avaliar o consumo de analgésicos e
anti-inflamatórios não esteróides, numa amostra de doentes seguidos na Unidade de
Reumatologia de ULS Castelo Branco, EPE.
Material e métodos: Realizou-se um estudo observacional retrospetivo com 462 doentes
seguidos na Consulta de Reumatologia, que decorreu no período de 1 de Janeiro de 2018 a 31
de Maio de 2018. Os dados foram recolhidos a partir de processos clínicos, utilizando-se o
software IBM SPSS Statistics® 25 e Phyton 3.7 para a análise estatística dos dados.
Resultados: Os doentes observados eram maioritariamente do sexo feminino (71%) e com uma
idade média de 63,66 anos. Verificou-se que a maioria dos doentes (56,70%) tinham um Índice
de Massa Corporal acima do normal e viviam principalmente em zonas rurais (61,90%). No que
diz respeito às patologias, a mais prevalente na amostra foi a Artrite Reumatóide (20,20%),
embora as Doenças do Tecido Conjuntivo (10,60%), as Espondiloartropatias (10,20%), a
Osteoartrose (10,20%) e a Fibromialgia (9,70%) também tenham tido uma prevalência
significativa. Em relação à medicação, verificámos que os anti-inflamatórios não esteróides
foram os fármacos mais consumidos, sendo que são mais os doentes que tomam estes fármacos
do que aqueles que não os tomam, numa percentagem de 52,16%. O naproxeno foi o antiinflamatório não esteróide mais utilizado (18,40%) e os inibidores seletivos da ciclo-oxigenase
2 eram tomados por 9,50% dos doentes. Verificou-se, ainda, que apenas 17,75% dos doentes
tomavam opióides, dos quais 7,79% eram opióides fortes e 9,96% eram opióides fracos.
Conclusões: Os anti-inflamatórios não esteróides são os fármacos mais consumidos nas várias
patologias reumáticas, sendo o naproxeno o mais utilizado. Os opióides são pouco usados, ainda
assim, verificou-se que a Fibromialgia e a Artrite Reumatóide são as patologias em que se
prescrevem mais opióides, havendo uma predominância na utilização do tramadol.
Introduction: Pain is a very significant symptom in rheumatological diseases, and it’s generally considered the main reason as to why patients look for doctors. Pain as a severe impact on patients, causing physical, psychic, social and economic problems. The treatment and control of pain in not only the duty of doctors and health professionals but also a right of the patients that suffer from it. However, the treatment can be difficult, especially when dealing with chronic diseases. It’s important to conduct research work about the medication used for pain treatment, given their potential epidemiological and evolutionary value, and also understand how alternative medication compares to conventional antalgic medication. Objectives: This work evaluates the consumption of analgesics and non-steroidal antiinflammatory drugs in patients, at Rheumatology Unit, ULS Castelo Branco, EPE. Methodology: This was a retrospective observational study with 462 patients followed at Rheumatology Unit appointments, which took place from the 1st of January 2018 to the 31st of May 2018. The collected data was retrieved from clinical files. IBM SPSS Statistics® 25 software and Phyton 3.7 were used for statistical analysis and data processing. Results: Most patients observed were female (71%) with an average age of 63.66 years. The majority of patients (56.70%) had a Body Mass Index above normal parameters and lived mostly in rural areas (61.90%). Regarding pathologies, the most significant was Rheumatoid Arthritis (20.20%), but Connective Tissue Diseases (10.6%), Spondyloarthropathies (10.2%), Osteoarthrosis (10.20%) and Fibromyalgia (9.70%) were also prevalent in the sample used in this study. Regarding medication, we verified that non-steroidal anti-inflammatory drugs were the most used drugs (52.16%), so there are more patients using these drugs than the ones who don’t. Naproxen was the most used non-steroidal anti-inflammatory drug (18.40%) and the cox2 enzyme inhibitors were consumed by 9.5% of patients. Also, we were able to verify that only 17.75% of patients use opioids, of which 7.79% were strong opioids and 9.96% were weak opioids. Conclusion: Non-steroidal anti-inflammatory drugs are the most used drugs for the various rheumatic pathologies, with naproxen being the one with the most use. Opioids are not widely used, yet we found that Fibromyalgia and Rheumatoid Arthritis are the pathologies in which opioids were most prescribed, with significant predominance of tramadol use.
Introduction: Pain is a very significant symptom in rheumatological diseases, and it’s generally considered the main reason as to why patients look for doctors. Pain as a severe impact on patients, causing physical, psychic, social and economic problems. The treatment and control of pain in not only the duty of doctors and health professionals but also a right of the patients that suffer from it. However, the treatment can be difficult, especially when dealing with chronic diseases. It’s important to conduct research work about the medication used for pain treatment, given their potential epidemiological and evolutionary value, and also understand how alternative medication compares to conventional antalgic medication. Objectives: This work evaluates the consumption of analgesics and non-steroidal antiinflammatory drugs in patients, at Rheumatology Unit, ULS Castelo Branco, EPE. Methodology: This was a retrospective observational study with 462 patients followed at Rheumatology Unit appointments, which took place from the 1st of January 2018 to the 31st of May 2018. The collected data was retrieved from clinical files. IBM SPSS Statistics® 25 software and Phyton 3.7 were used for statistical analysis and data processing. Results: Most patients observed were female (71%) with an average age of 63.66 years. The majority of patients (56.70%) had a Body Mass Index above normal parameters and lived mostly in rural areas (61.90%). Regarding pathologies, the most significant was Rheumatoid Arthritis (20.20%), but Connective Tissue Diseases (10.6%), Spondyloarthropathies (10.2%), Osteoarthrosis (10.20%) and Fibromyalgia (9.70%) were also prevalent in the sample used in this study. Regarding medication, we verified that non-steroidal anti-inflammatory drugs were the most used drugs (52.16%), so there are more patients using these drugs than the ones who don’t. Naproxen was the most used non-steroidal anti-inflammatory drug (18.40%) and the cox2 enzyme inhibitors were consumed by 9.5% of patients. Also, we were able to verify that only 17.75% of patients use opioids, of which 7.79% were strong opioids and 9.96% were weak opioids. Conclusion: Non-steroidal anti-inflammatory drugs are the most used drugs for the various rheumatic pathologies, with naproxen being the one with the most use. Opioids are not widely used, yet we found that Fibromyalgia and Rheumatoid Arthritis are the pathologies in which opioids were most prescribed, with significant predominance of tramadol use.
Description
Keywords
Analgésicos Anti-Inflamatórios Não Esteroides Dor Opióides Reumatologia